---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-013619"
form_type: "8-K"
ticker: "ARWR"
cik: "0000879407"
company_name: "ARROWHEAD PHARMACEUTICALS, INC."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T12:41:44.072317+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Arrowhead shareholders elect eight directors, approve executive compensation, ratify KPMG

## Summary
- All eight director nominees elected with majority support; Douglas Ingram received 68.9M for vs 13.8M against.
- Advisory vote to approve executive compensation passed with 75.3M for, 7.4M against.
- Advisory vote on frequency of future say-on-pay selected 1 year with 79.9M votes.
- Ratification of KPMG as independent auditors approved with 101.0M for, 1.2M against.
- Over 102.7M shares voted out of 125.1M outstanding; all proposals passed.

## SEC filing metadata
- accession: 0001628280-25-013619
- form_type: 8-K
- ticker: ARWR
- cik: 0000879407
- company_name: ARROWHEAD PHARMACEUTICALS, INC.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879407/000162828025013619/0001628280-25-013619-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879407/000162828025013619/arwr-20250312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-013619
- JSON: https://secwatch.observer/filing/0001628280-25-013619.json
- Plain text: https://secwatch.observer/filing/0001628280-25-013619.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.